FDA approves drug for relapsing multiple sclerosis

November 16, 2014 6:28 PM

2 0

NEW YORK – The Food and Drug Administration has approved Lemtrada, a treatment for relapsing multiple sclerosis made by the drugmaker Genzyme.

The drug has already been approved by the European Medicines Agency for use in the European Union and in Canada and Australia. Late last year, the FDA had said that the drug was not ready for approval in the U.S. market.

Read more

To category page